PPI use in the OTC era: Who to treat, with what, and for how long?

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 3, 2005, Pages 208-215

  Inadomi, John M ^a,b,c   Fendrick, A Mark ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Center for Practice Management and Outcomes Research   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; AZD 0865; CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; GENERIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIDAZOPYRIDINE DERIVATIVE; NON PRESCRIPTION DRUG; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; UNCLASSIFIED DRUG;

BARRETT ESOPHAGUS; CLINICAL TRIAL; COST CONTROL; DRUG COST; DRUG EFFICACY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; NONHUMAN; PATHOLOGY; QUALITY OF LIFE; REFLUX ESOPHAGITIS; REMISSION; REVIEW; SELF MEDICATION; SYMPTOM;

ANTACIDS; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUGS, NON-PRESCRIPTION; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; PATIENT PARTICIPATION; PATIENT SELECTION; PROTON PUMPS; SELF MEDICATION;

EID: 17644375503     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00717-7     Document Type: Review

References (47)

1. N. Chiba Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis a systematic overview Can J Gastroenterol 11 Suppl B 1997 66B 73B
2. K.D. Bardhan The role of proton pump inhibitors in the treatment of gastrooesophageal reflux disease Aliment Pharmacol Ther 9 Suppl 1 1995 15 25
3. P.J. Kahrilas Strategies for medical management of reflux disease Best Pract Res Clin Gastroenterol 14 2000 775 791
4. S. Vigneri, R. Termini, G. Leandro A comparison of five maintenance therapies for reflux esophagitis N Engl J Med 333 1995 1106 1110
5. J. Dent, N.D. Yeomans, M. Mackinnon Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety Gut 35 1994 590 598
6. E.C. Klinkenberg-Knol, H.P. Festen, J.B. Jansen Long-term treatment with omeprazole for refractory reflux esophagitis efficacy and safety Ann Intern Med 121 1994 161 167
7. S.J. Sontag Rolling review gastro-oesophageal reflux disease Aliment Pharmacol Ther 7 1993 293 312
8. T. Lind, T. Havelund, L. Lundell On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial Aliment Pharmacol Ther 13 1999 907 914
9. P. Bytzer, A.L. Blum Rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease Aliment Pharmacol Ther 20 2004 389 398
10. N.J. Talley, K. Lauritsen, H. Tunturi-Hihnala Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease a controlled trial of 'on-demand' therapy for 6 months Aliment Pharmacol Ther 15 2001 347 354
11. N.J. Talley, T.L. Venables, J.R. Green Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease a placebo-controlled trial of on-demand therapy for 6 months Eur J Gastroenterol Hepatol 14 2002 857 863
12. N.O. Stalhammar, J. Carlsson, R. Peacock Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease Pharmacoeconomics 16 1999 483 497
13. K.D. Bardhan, S. Muller-Lissner, M.A. Bigard Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group BMJ 318 1999 502 507
14. K.D. Bardhan Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease Am J Gastroenterol 98 Suppl 3 2003 S40 S48
15. S.D. Ladas, P.S. Tassios, S.A. Raptis Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole use of 24-hour gastric pH monitoring Am J Gastroenterol 95 2000 374 380
16. R. Faaij, J. van Gerven, I. Jolivet-Landreau Onset of action during on-demand treatment with Maalox suspension or low-dose ranitidine for heartburn Aliment Pharmacol Ther 13 1999 1605 1610
17. O. Grove, C. Bekker, M.G. Jeppe-Hansen Ranitidine and high-dose antacid in reflux oesophagitis A randomized, placebo-controlled trial Scand J Gastroenterol 20 1985 457 461
18. R. Weberg, A. Berstad Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis Scand J Gastroenterol 24 1989 401 406
19. D.A. Lieberman Medical therapy for chronic reflux esophagitis Long-term follow-up Arch Intern Med 147 1987 1717 1720
20. M. Elm, P. Hellke, K. Andren Time to relief of episodic symptoms of gastro-oesophageal reflux disease A crossover comparison of single doses of the effervescent and standard formulations of ranitidine Scand J Gastroenterol 33 1998 900 904
21. T. Johannessen, P. Kristensen On-demand therapy in gastroesophageal reflux disease a comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets Clin Ther 19 1997 73 81
22. J.P. Galmiche, G. Shi, B. Simon On-demand treatment of gastro-oesophageal reflux symptoms a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo Aliment Pharmacol Ther 12 1998 909 917
23. I. Wilhelmsen, J.G. Hatlebakk, S. Olafsson On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life Aliment Pharmacol Ther 13 1999 1035 1040
24. J.M. Inadomi, R. Jamal, G.H. Murata Step-down management of gastroesophageal reflux disease Gastroenterology 121 2001 1095 1100
25. J.M. Inadomi, L. McIntyre, L. Bernard Step-down from multiple- to single-dose proton pump inhibitors (PPIs) a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs Am J Gastroenterol 98 2003 1940 1944
26. J.M. Inadomi On-demand and intermittent therapy for gastro-oesophageal reflux disease economic considerations Pharmacoeconomics 20 2002 565 576
27. A.M. Fendrick, M. Shaw, B. Schactel Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn Clin Gastroenterol Hepatol 2 2004 17 21
28. G. Tytgat Shortcomings of the first-generation proton pump inhibitors Eur J Gastroenterol Hepatol 13 Suppl 1 2001 S29 S33
29. W. Chey, J. Inadomi, A. Booher Primary care physicians' perceptions and practices on the management of GERD results of a national survey Gastroenterology 124 Suppl 1 2003 A505
30. L.B. Barradell, D. McTavish Omeprazole a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis Pharmacoeconomics 3 1993 482 510
31. N. Talley, V. Stanghellini, R. Heading Functional gastroduodenal disorders Gut 45 Suppl 2 1999 II37 II42
32. J.J. Ofman, G.H. Dorn, M.B. Fennerty The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 2002 261 273
33. R. Fass, J.J. Ofman, R.E. Sampliner The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis Aliment Pharmacol Ther 14 2000 389 396
34. J. Inadomi, A. Fendrick Dyspepsia Physicians Information and Education Resource 2003 American College of Physicians-American Society of Internal Medicine Available: http://pier.acponline.org/physicians/diseases/d169
35. A.P. Hungin, G. Rubin, H. O'Flanagan Factors influencing compliance in long-term proton pump inhibitor therapy in general practice Br J Gen Pract 49 1999 463 464
36. E.H. Boath, A. Blenkinsopp The rise and rise of proton pump inhibitor drugs patients' perspectives Soc Sci Med 45 1997 1571 1579
37. A.P. Hungin, G.P. Rubin, H. O'Flanagan Long-term prescribing of proton pump inhibitors in general practice Br J Gen Pract 49 1999 451 453
38. P. Bytzer, A. Blum, D. De Herdt Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease Aliment Pharmacol Ther 20 2004 181 188
39. S. Kaspari, L. Kupcinskas, R. Fischer On-demand therapy with pantoprazole 20 mg as effective long-term management of patients suffering from mild GERD Gastroenterology 124 Suppl 1 2003 A538
40. T. Scholten, G. Gatz, P. Sander On-demand therapy with pantoprazole 20mg od for the long-term management of GERD patients previously healed from heartburn Gut 49 Suppl 3 2001 A64
41. R. Fass, G. Pulliam, C. Johnson Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux Age Ageing 29 2000 125 130
42. A.L. Blum, R. Arnold, M. Stolte Short course acid suppressive treatment for patients with functional dyspepsia results depend on helicobacter pylori status Gut 47 2000 473 480
43. S.J. Veldhuyzen van Zanten, C. Cleary, N.J. Talley Drug treatment of functional dyspepsia a systematic analysis of trial methodology with recommendations for design of future trials Am J Gastroenterol 91 1996 660 673
44. N.J. Talley, V. Meineche-Schmidt, P. Pare Efficacy of omeprazole in functional dyspepsia double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) Aliment Pharmacol Ther 12 1998 1055 1065
45. P.G. Farup, O. Hovde, R. Torp Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern Scand J Gastroenterol 34 1999 575 579
46. K. Andersson, A.A. Holmberg, C. Briving Preclinical profile of AZD0865, a novel, selective, potassium-competitive acid blocker Gastroenterology 126 Suppl 2 2004 A56
47. B. Holstein, A. Holmberg, M. Florentzson Pharmacokinetic and pharmacodynamic profiles of AZD0865, a novel, potassium-competitive acid blocker Gastroenterology 126 Suppl 2 2004 A334